AA
Andreas Argyrides Oppenheimer Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Abeona Therapeutics
ABEO
$356M
| $6.95 | $20 |
188%
upside
| Outperform | 19 days ago |
|
2
Dyne Therapeutics
DYN
$1.95B
| $13.72 | $13 |
5%
downside
| Outperform | 28 days ago |
|
3
Harmony Biosciences
HRMY
$2.14B
| $37.27 | $61 |
64%
upside
| Outperform | 3 months ago |
|
4
Aquestive Therapeutics
AQST
$472M
| $3.90 | $7 |
79%
upside
| Outperform | 3 months ago |
|
5
Liquidia Corp
LQDA
$2.51B
| $29.14 | $13 |
55%
downside
| Underperform | 3 months ago |
|
6
Keros Therapeutics
KROS
$649M
| $15.98 | $15 |
6%
downside
| Neutral | 7 months ago |
|
|
7
Keros Therapeutics
KROS
$649M
| $15.98 | $23 |
44%
upside
| Outperform | 7 months ago |
|
8
Ascendis Pharma
ASND
$12.2B
| $201.35 | $181 |
10%
downside
| Outperform | 9 months ago |
|
9
Benitec Biopharma
BNTC
$354M
| $13.49 | $35 |
159%
upside
| Outperform | 10 months ago |
|
10
Larimar Therapeutics
LRMR
$334M
| $3.90 | $26 |
567%
upside
| Outperform | 10 months ago |
|
11
MoonLake Immunotherapeutics
MLTX
$3.87B
| $60.99 | $104 |
71%
upside
| Outperform | 1 year ago |
|
12
Gossamer Bio
GOSS
$607M
| $2.67 | $9 |
237%
upside
| Outperform | 1 year ago |
|
|
13
MoonLake Immunotherapeutics
MLTX
$3.87B
| $60.99 | $92 |
51%
upside
| Outperform | 1 year ago |
|
14
ARS Pharmaceuticals
SPRY
$1.08B
| $10.92 | $19 |
74%
upside
| Outperform | 1 year ago |
|
|
15
Aquestive Therapeutics
AQST
$472M
| $3.90 | $9 |
131%
upside
| Outperform | 1 year ago |
|
|
16
Gossamer Bio
GOSS
$607M
| $2.67 | $6 |
125%
upside
| Outperform | 1 year ago |
|
17
Oculis Holding
OCS
$854M
| $16.32 | $29 |
78%
upside
| Outperform | 1 year ago |
|
18
Regenxbio
RGNX
$470M
| $9.30 | $21 |
126%
upside
| Neutral | 1 year ago |
|
19
Sarepta Therapeutics
SRPT
$1.94B
| $18.57 | $224 |
1,106%
upside
| Outperform | 1 year ago |
|
20
Pacira BioSciences
PCRX
$1.23B
| $27.32 | $57 |
109%
upside
| Outperform | 1 year ago |
|
|
21
Liquidia Corp
LQDA
$2.51B
| $29.14 | $3 |
90%
downside
| Underperform | 1 year ago |
|
22
MannKind Corp
MNKD
$1.8B
| $5.88 | $10 |
70%
upside
| Outperform | 1 year ago |
|
23
BioMarin Pharmaceuticals
BMRN
$11.4B
| $59.56 | $70 |
18%
upside
| Neutral | 2 years ago |
|